To evaluate the antitumor activity of FX1 + etoposide in a more clinically relevant mouse model, we established a patient-derived xenograft model of lung adenocarcinoma harboring a G12V mutation in KRAS (LACPDX). Here, KRAS is linked to lung adenocarcinoma.